vs
Immunovant, Inc.(IMVT)与美国合众银行(SFBC)财务数据对比。点击上方公司名可切换其他公司
美国合众银行的季度营收约是Immunovant, Inc.的1.1倍($9.5M vs $8.4M),Immunovant, Inc.同比增速更快(140.7% vs 1.5%),美国合众银行自由现金流更多($7.0M vs $-59.8M)
Immunovant是一家临床阶段生物制药企业,专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法,其核心在研候选产品覆盖多种自身免疫适应症,面向全球医疗市场布局研发管线。
美国合众银行是一家美国跨国银行机构,总部位于明尼苏达州明尼阿波利斯,在特拉华州注册成立。截至2025年,它是美国第五大银行,也是美国中西部规模最大的银行,被金融稳定委员会认定为具有系统重要性的金融机构,主营银行、投资、抵押贷款等相关金融服务。
IMVT vs SFBC — 直观对比
营收规模更大
SFBC
是对方的1.1倍
$8.4M
营收增速更快
IMVT
高出139.2%
1.5%
自由现金流更多
SFBC
多$66.8M
$-59.8M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $8.4M | $9.5M |
| 净利润 | $-75.3M | — |
| 毛利率 | — | — |
| 营业利润率 | -896.2% | 27.1% |
| 净利率 | -899.0% | — |
| 营收同比 | 140.7% | 1.5% |
| 净利润同比 | -26.7% | — |
| 每股收益(稀释后) | $-0.50 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IMVT
SFBC
| Q4 25 | — | $9.5M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $9.2M | ||
| Q4 24 | — | $9.4M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | — | $8.6M | ||
| Q1 24 | $8.4M | $8.6M |
净利润
IMVT
SFBC
| Q4 25 | — | — | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | $2.1M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $795.0K | ||
| Q1 24 | $-75.3M | $770.0K |
营业利润率
IMVT
SFBC
| Q4 25 | — | 27.1% | ||
| Q3 25 | — | 21.3% | ||
| Q2 25 | — | 24.5% | ||
| Q1 25 | — | 15.9% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 11.4% | ||
| Q1 24 | -896.2% | 10.9% |
净利率
IMVT
SFBC
| Q4 25 | — | — | ||
| Q3 25 | — | 17.3% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 12.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | -899.0% | 9.0% |
每股收益(稀释后)
IMVT
SFBC
| Q4 25 | — | $0.87 | ||
| Q3 25 | — | $0.66 | ||
| Q2 25 | — | $0.79 | ||
| Q1 25 | — | $0.45 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | — | $0.45 | ||
| Q2 24 | — | $0.31 | ||
| Q1 24 | $-0.50 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $138.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $109.4M |
| 总资产 | $666.4M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IMVT
SFBC
| Q4 25 | — | $138.5M | ||
| Q3 25 | — | $101.2M | ||
| Q2 25 | — | $102.5M | ||
| Q1 25 | — | $131.5M | ||
| Q4 24 | — | $43.6M | ||
| Q3 24 | — | $148.9M | ||
| Q2 24 | — | $135.1M | ||
| Q1 24 | $635.4M | $138.0M |
股东权益
IMVT
SFBC
| Q4 25 | — | $109.4M | ||
| Q3 25 | — | $107.5M | ||
| Q2 25 | — | $106.0M | ||
| Q1 25 | — | $104.4M | ||
| Q4 24 | — | $103.7M | ||
| Q3 24 | — | $102.2M | ||
| Q2 24 | — | $101.3M | ||
| Q1 24 | $617.8M | $101.0M |
总资产
IMVT
SFBC
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $993.6M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | $666.4M | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $7.0M |
| 自由现金流率自由现金流/营收 | -714.4% | 73.4% |
| 资本支出强度资本支出/营收 | 1.8% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $12.0M |
8季度趋势,按日历期对齐
经营现金流
IMVT
SFBC
| Q4 25 | — | $7.2M | ||
| Q3 25 | — | $3.8M | ||
| Q2 25 | — | $-494.0K | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | $-59.7M | $3.5M |
自由现金流
IMVT
SFBC
| Q4 25 | — | $7.0M | ||
| Q3 25 | — | $3.8M | ||
| Q2 25 | — | $-518.0K | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | $-59.8M | $1.9M |
自由现金流率
IMVT
SFBC
| Q4 25 | — | 73.4% | ||
| Q3 25 | — | 38.3% | ||
| Q2 25 | — | -5.0% | ||
| Q1 25 | — | 19.8% | ||
| Q4 24 | — | 30.4% | ||
| Q3 24 | — | 35.5% | ||
| Q2 24 | — | -65.4% | ||
| Q1 24 | -714.4% | 22.2% |
资本支出强度
IMVT
SFBC
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 18.7% | ||
| Q1 24 | 1.8% | 19.0% |
现金转化率
IMVT
SFBC
| Q4 25 | — | — | ||
| Q3 25 | — | 2.24× | ||
| Q2 25 | — | -0.24× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.84× | ||
| Q2 24 | — | -5.05× | ||
| Q1 24 | — | 4.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图